Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail

NCT02928692 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT02928692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail
Lead sponsor
RenJi Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2016
Completion date
December 31, 2021
Enrollment
750 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of the rectum, colon cancer, prostate cancer, renal carcinoma